FLII and acquired epidermolysis bullosa: Recent studies have described the contribution of Flii over-expression in exacerbation of inflammatory conditions, including psoriasiform dermatitis (24) and an autoimmune inflammation-mediated epidermolysis bullosa acquisita (23, 32).